Lundbeck, Longboard Pharmaceuticals
Longboard Pharmaceuticals’ stock soars amid Lundbeck’s $2.6 billion deal to acquire the company
H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.
Lundbeck to Buy Longboard Pharma in $2.6 Billion Deal
Lundbeck A/S agreed to acquire Longboard Pharmaceuticals Inc in a $2.6 billion deal that boosts its drug pipeline for serious brain diseases.The Danish pharmaceutical company is offering shareholders $60 per share in cash for US-based Longboard,
Why Is Epilepsy Focused Longboard Pharmaceuticals Stock Trading Higher On Monday?
Denmark-based H. Lundbeck A/S on Monday agreed to acquire Longboard Pharmaceuticals, Inc (NASDAQ:LBPH) for $60.00 per share in cash. The transaction is valued at approximately $2.6 billion in equity value and $2.
Lundbeck to buy neurology-focused Longboard Pharmaceuticals in $2.6 billion deal
The Danish pharma company Lundbeck said Monday it would buy Longboard Pharmaceuticals in a deal worth $2.6 billion
Longboard Pharmaceuticals Shares Hit All-Time High on Takeover by Lundbeck
Longboard Pharmaceuticals shares surged by more than 50%, and hit an all-time high Monday, after the clinical-stage biopharmaceutical company agreed to be acquired by Danish drugmaker H. Lundbeck for about $2.6 billion.
Denmark's Lundbeck bets on epilepsy drug with $2.6 billion Longboard deal
The companies said Lundbeck will acquire all of Longboard's shares for $60 per share, which represents a premium of 54.2% to the stock's last close of $38.90. Longboard's lead drug candidate, bexicaserin,
Denmark's H. Lundbeck To Buy Longboard Pharmaceuticals For $60/share Cash
Danish pharmaceutical company H. Lundbeck A/S (HLUKY.PK, HLUKF.PK) and Longboard Pharmaceuticals, Inc. (LBPH), announced Monday an
Longboard Pharmaceuticals Stock Soars 51%. It’s Being Bought for $2.6 Billion.
Pharmaceutical company Lundbeck will acquire Nasdaq-listed Longboard Pharmaceuticals in a $2.6 billion deal, the two companies said Monday. Denmark-listed H. Lundbeck will make a tender offer for all shares outstanding of Longboard common stock,
FierceBiotech5h
Lundbeck signs $2.5B check for Longboard, seeing blockbuster potential in epilepsy med
After spying blockbuster potential in Longboard Pharmaceuticals’ epilepsy med, brain disease-focused pharma Lundbeck is ...
Business Insider9h
Longboard Shares Surge In Pre-market On News Of Acquisition
(RTTNews) - Shares of Longboard Pharmaceuticals, Inc. (LBPH) were surging more than 50 percent in pre-market on Monday on the news of it being acquired by H. Lundbeck A/S in a transaction valued ...
The Inertia on MSN17h
Rachael Tilly, Taylor Jensen Win 2024 World Longboard Titles
Rachael Tilly and Taylor Jensen won the Surf City El Salvador Longboard Championships to claim 2024 World Longboard Titles.
Longboard Pharmaceuticals' stock soars on Lundbeck’s $2.6 billion deal to acquire the company
Shares of Longboard Pharmaceuticals Inc. were soaring more than 51% on Monday after the announcement of H. Lundbeck’s $2.6 billion deal to acquire the California-based clinical-stage biopharmaceutical ...
Business Times5h
Lundbeck to buy Longboard Pharma in US$2.6 billion deal
H Lundbeck agreed to acquire Longboard Pharmaceuticals in a US$2.6 billion deal that boosts its drug pipeline for serious ...